Pluri Inc. — Director's Dealing 2010

Nov 1, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2010-10-28

Reporting Person: Aberman Zami (Director, CEO & Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-10-28	Common Stock	A	160000	—	Acquired	899151	Direct

Footnotes

F1: The shares vest as follows: 25% after 6 months from grant and the remaining shares vest in 6 equal installments every 3
months.